Department of Medicine QA&I Committee

 

The Medicine QA&I Committee has a broad range of activities:

  • Evaluates performance of department on internal, institutional, and regulatory standards
  • Assists in developing and coordinating new quality initiatives and metrics for the department
  • Conducts adverse event, mortality, and case reviews
  • Provides forum for sharing information about QI and patient safety activities across divisions
  • Reviews and adjudicates High Value Care Project proposals

 

The current membership of the committee is listed below.  Please contact Allen Repp or your divisional representative with questions.

MemberGroup

Allen Repp, MD

Committee Chair

Allen Mead, MHSA

Administration

Pam Stevens, RN, MSN

Jeffords Institute for Quality

Amanda Kennedy, PharmD

Dept. of Medicine Quality Scholar

Bradley Tompkins, MPH, MS

Dept. of Medicine Quality Analyst

Stephen DeVoe, MPH, MS

Dept. of Medicine Quality Program Project Director

Peter VanBuren, MD

Cardiovascular Medicine

Melanie Bui, MD, PhD

Dermatology

Juan Pablo Perdomo Rodriguez, MD

Endocrinology and Diabetes

Richard Zubarik, MD

Gastroenterology and Hepatology

Marie Sandoval, MD

General Internal Medicine and Geriatrics

Farrah Khan, MD

Hematology and Oncology

Mark Pasanen, MD

Hospital Medicine

Timothy Whitman, DO

Infectious Disease

Jeffrey Rimmer, MD

Nephrology

Gil Allen, MD

Pulmonary Disease and Critical Care

Scott Legunn, MD

Rheumatology and Clinical Immunology

Julia Powelson, MD

Elizabeth Wahlberg, MD

Kramer Wahlberg, MD

Chief Residents

Maria Airoldi, RPh

Pharmacy

Tammy Berrings, RN (B4), Susan Bellemare, RN (M5), Peg Gagne, RN

Nursing